Yingpeng Zhao

机构：The First Hospital of Kunming, State Key Laboratory of Vehicle NVH and Safety Technology, Tsinghua University

发表论文 24 篇 · 总被引 595 次 · h-index 8

代表论文

• Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma (2023 · Molecular Cancer · 被引 320)
• Experiments and microsimulation of high-pressure single-cell PEM electrolyzer (2022 · Applied Energy · 被引 68)
• miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling (2017 · Cancer Cell International · 被引 63)
• Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3 (2023 · Molecular Biology Reports · 被引 32)
• MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24 (2023 · Life Sciences · 被引 26)
• Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study (2021 · Hepatobiliary & pancreatic diseases international · 被引 13)